Organisation paid for research Program year 2024 Source: CMS Open Payments

Advanced Vision Care

Neither a doctor nor a teaching hospital

Research payments

$525,079

73 payments

Through program year 2024, Advanced Vision Care is reported as receiving $525,079 in research payments, across 73 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$205,745	7
2023	Research	$36,550	7
2022	Research	$72,248	11
2021	Research	$185,822	46
2020	Research	$24,714	2

Breakdown

Who paid Research payments · program years 2020–2024

Ocular Therapeutix, Inc. $472,629 70 payments
Carl Zeiss Meditec, Inc. $50,000 1 payment
Bausch & Lomb Americas Inc. $2,450 2 payments

Studies the money was for Research payments · program years 2020–2024

Assessing the efficacy and safety of DEXTENZA, sustained release dexamtheasone 0.4mg insert, when placed within the lower and upper eye lid canaliculus in conjunction with topical prednisolone acetate 1% for the treatment of pain, and inflammation following corneal transplant surgery (PKP, DSEK, DMEK) as compared to topical prednisolone acetate 1% monotherapy $396,790 61 payments
Accuracy of IOLM700 TK in Post-LVC patients undergoing Cataract Surgery $50,000 1 payment
DEXTENZA compared to compounded drops post cataract surgery $28,485 5 payments
The CORNEA Study $24,714 2 payments
A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Insert Prior to or Following Corneal Transplant or Cataract Surgery $21,640 1 payment
Post-Approval Follow-Up Study of the Ic-8 Apthera Iol $2,450 2 payments
Inserter Study $1,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.